why choose us

First received: November 29, 2024

Clinical Trial: Impact Of Metformin In Rectal Cancer Patients

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Rectal Cancer Patients

Study Type: INTERVENTIONAL


Official Title: Metformin Enhances Pathological Complete Response in Non-Diabetic Rectal Cancer Patients Undergoing Neoadjuvant Chemoradiotherapy: A Randomized Controlled Trial

Brief Summary: Design: Prospective, randomized controlled clinical trial Setting: at Minia University Hospital and Minia Oncology Institute.Condition: Colorectal cancer.To be eligible for participation, patients must meet the following criteria:Histologically confirmed diagnosis of rectal adenocarcinoma.Age starting from 18 and older.Eastern Cooperative Oncology Group (ECOG) performance status of 0-2.Adequate organ function (renal, hepatic, and hematological)Signed informed consent.Patients will be randomized into two…

Read more